PMC:7228307 / 1434-1685 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7228307","sourcedb":"PMC","sourceid":"7228307","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7228307","text":"hips between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” therapeutic antibodies. Such development strategies now include focused glycan or protein engineering of the Fc to increase affinity and/or tailor specificity for s","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"25","span":{"begin":159,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"tao:has_database_id","subj":"25","obj":"MESH:D011134"},{"subj":"25","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8","span":{"begin":169,"end":176},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma67257"},{"subj":"T8","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T16","span":{"begin":13,"end":15},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T17","span":{"begin":16,"end":18},"obj":"http://purl.obolibrary.org/obo/CLO_0008882"},{"id":"T18","span":{"begin":151,"end":158},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"},{"id":"T19","span":{"begin":196,"end":198},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"attributes":[{"subj":"T16","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T17","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T18","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T19","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":169,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"subj":"T6","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T2","span":{"begin":169,"end":176},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"subj":"T2","pred":"source","obj":"LitCovid-sample-CHEBI"}]},{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"25","span":{"begin":159,"end":165},"obj":"Chemical"}],"attributes":[{"id":"A25","pred":"pubann:denotes","subj":"25","obj":"MESH:D011134"},{"subj":"25","pred":"source","obj":"LitCovid-sample-Pubtator"}]},{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T8","span":{"begin":169,"end":176},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"fma_id","subj":"T8","obj":"http://purl.org/sig/ont/fma/fma67257"},{"subj":"T8","pred":"source","obj":"LitCovid-sample-PD-FMA"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#b793ec","default":true},{"id":"LitCovid-PD-FMA-UBERON","color":"#93ec9d"},{"id":"LitCovid-PD-CLO","color":"#ec93a2"},{"id":"LitCovid-PD-CHEBI","color":"#93bcec"},{"id":"LitCovid-sample-CHEBI","color":"#d6ec93"},{"id":"LitCovid-sample-Pubtator","color":"#e793ec"},{"id":"LitCovid-sample-PD-FMA","color":"#93eccd"}]}]}}